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Available online 3 January 2015Abstract Neuroblasts represent the predominant migrating cell type in the adult mouse brain. There are, however, increasing
evidences of migration of other neural precursors. This work aims at identifying in vivo endogenous early neural precursors,
different from neuroblasts, able to migrate in response to brain injuries. The monoclonal antibody Nilo1, which unequivocally
identifies type B astrocytes and embryonic radial glia, was coupled to magnetic glyconanoparticles (mGNPs). Here we show that
Nilo1–mGNPs in combination with magnetic resonance imaging in living mice allowed the in vivo identification of endogenous type
B astrocytes at their niche, as well as their migration to the lesion site in response to glioblastoma, demyelination, cryolesion or
mechanical injuries. In addition, Nilo1+ adult radial glia-like structures were identified at the lesion site a few hours after damage.
For all damage models used, type B astrocyte migration was fast and orderly. Identification of Nilo1+ cells surrounding an induced
glioblastoma was also possible after intraperitoneal injection of the antibody. This opens up the possibility of an early
identification of the initial damage site(s) after brain insults, by the migration of type B astrocytes.
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115Detection of mouse endogenous type B astrocytes migrating towards brain lesionsIntroduction site are compatible with the migration of committed andNeural stem cells in adult rodents are mainly restricted to
the niches at the subventricular zone (SVZ) in the lateral
ventricles and the subgranular zone (SGZ) in the hippocam-
pal dentate gyrus (Doetsch et al., 1999; Palmer et al., 1997;
Reynolds and Weiss, 1992; Richards et al., 1992). In the adult
SVZ, type B cells express glial markers, have astrocyte
characteristics, bundles of intermediate filaments and
multiple processes (Doetsch et al., 1999; Peters et al.,
1991), and generate neuroblasts (type A cells, neuronal
precursors) through a highly proliferative transit amplifying
population (type C cells) (Doetsch et al., 1999; Kriegstein
and Alvarez-Buylla, 2009). The cell bodies of type B
astrocytes are generally located under the ependymal layer
of the lateral ventricles, have short processes that extend
through it, with small apical endings on the ventricle, in
addition to frequently tangentially oriented long basal pro-
cesses with specialized end feet on blood vessels (Kriegstein
and Alvarez-Buylla, 2009; Mirzadeh et al., 2008). Thus, adult
SVZ B cells, similarly to the radial glia (RG) during develop-
ment, retain an apical–basal polarity and are part of the
ventricular epithelium (Kriegstein and Alvarez-Buylla, 2009). In
fact, although the radial glia disappears postnatally by
transformation into parenchymal astrocytes, some radial glial
cells persist within the adult SVZ hidden among astrocytes of
the glial tubes. This modified radial glia belongs to the
astroglial lineage (type B cells) and maintains self-renewal
potential and pluripotency, the two stem cell characteristics
(Bonfanti and Peretto, 2007; Gubert et al., 2009;
Sundholm-Peters et al., 2004).
It is well documented the migration of adult neuroblasts
in a pathway known as rostral migratory stream (RMS), in
longitudinal clusters from their SVZ niche towards the
olfactory bulb (OB), where dying neurons should be replaced
(Doetsch et al., 1999; Doetsch and Alvarez-Buylla, 1996; Lois
and Alvarez-Buylla, 1994; Lois et al., 1996). In addition,
migration of cells from SVZ towards non-olfactory bulb regions
in the adult has been reported on several disease or injury
models (Arvidsson et al., 2002; Cantarella et al., 2008;
Nakatomi et al., 2002; Thored et al., 2006). Surgical RMS
disruption led to migration of BdrU+PSA-NCAM+ cells from the
SVZ into the anterior olfactory nucleus, the frontal cortex and
the striatum (Alonso et al., 1999; Jankovski et al., 1998). In
addition, in response to an induced brain tumor, themigration
of endogenous neuroblasts towards the lesion site could be
followed in vivo by MRI (Elvira et al., 2012). Although DCX+
neuroblasts are thought to be the major migratory SVZ cells,
type C cells might migrate as well (Aguirre and Gallo, 2004).
Many of the migration experiments have been done using
BrdU-labeled cells, where some, but not all the labeled cells
were neuroblasts (Arvidsson et al., 2002; Cantarella et al.,
2008; Nakatomi et al., 2002; Thored et al., 2006; Gotts and
Chesselet, 2005; Sundholm-Peters et al., 2005). Indeed,
several reports suggest that other precursor cells from the
SVZ are able to migrate towards a brain lesion site. For
instance, on transgenic mice expressing a nestin driven
green fluorescent protein (GFP), in response to a glioblas-
toma, the GFP+ cells surrounding the brain tumor were
actively dividing (Ki67+), mushashi+, glial precursors (NG2+),
GFAP+, PSA-NCAM+ or DCX+. These phenotypes at the lesionnon-committed precursors (Glass et al., 2005). Time-lapse
experiments showed that among the nestin-eGFP+ cells in the
SVZ, there were type C cells, GFAP+ cells, neuroblasts,
ependymal cells and microglia, where a high percentage of
motile nestin-eGFP+ cells were DCX− (Nam et al., 2007). Taken
together, these data suggest that DCX+ neuroblasts do not
represent the only motile SVZ-derived cells in the postnatal
mouse brain. In cortical injuries, NG2+ cells, Nestin+ GFAP+
cells or SVZ cells able to differentiate into glia were identified
in the vicinity of the lesion site at different time points (Glass
et al., 2005; Goings et al., 2004; Picard-Riera et al., 2002;
Holmin et al., 1997).
We hypothesized that type B astrocytes might be among
the other SVZ-derived cell types able to migrate in response
to a damage insult. In this study we used Nilo1, a previously
characterized mAb that identifies early neural progenitors in
the SVZ niche (Del Valle et al., 2010), demonstrating that
Nilo1+ cells showed an immunophenotype and subependymal
localization compatible with B astrocytes. After coupling
Nilo1 mAb to magnetic nanoparticles, we followed by MRI
and confirmed by immunohistochemistry the fast mobiliza-
tion of B astrocytes towards the lesion site, as a trait shared
by different brain injuries in adult mice.Materials and methods
Animals
Experiments involving animals were performed in compliance
with the European Union and Spanish laws (Council Directive
86/609/EEC) and approved by the CSIC Committee of Animal
Experimentation. For these experiments, 6–8 week old
C57Bl/6J mice (males), bred and housed in our animal facility
under standard conditions were used. Surgery was performed
under anesthesia, and efforts were made to minimize suffering
of the animals.Antibodies
Nilo1 and Nilo2 mAbs were generated by the fusion of
hamster B cells and the mouse myeloma X63Ag8, as
described (Del Valle et al., 2010). Purification of Nilo1 and
Nilo2, biotinylation and Cy5 labeling was from ProteinTools
(CNB-CSIC, Madrid, Spain). Commercial antibodies and other
reagents are described in Supplementary material Table S1.
Characterization of the protein G-magnetic
glyconanoparticles (mGNPs) and coupling to Nilo1
Water-soluble magnetic glyconanoparticles, consisting on a
magnetic core (4 nm of diameter) covered with a 1 nm gold
shell and coated with carbohydrates and an amphiphilic
linker ended in a carboxyl group, were prepared and
characterized as previously described (Gallo et al., 2010).
Recombinant protein G was covalently immobilized to
these particles, which enabled the subsequent capture of
IgG antibodies (Gallo et al., 2011; García et al., 2011).
Characterization of protein G-glyconanoparticles (mGNPs)
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(Elvira et al., 2012). mGNPs (100 μg) were incubated 5 h at
4 °C with Nilo1 mAb (135 μg) in 0.1 M glycine buffer pH 9.0
on a final volume of 50 μl. Characterization of the amount
and functionality of the coupled antibody was made as
described (Elvira et al., 2012).
Cell culture
CT-2A mouse astrocytoma (a gift from Prof. T.N. Seyfried,
Boston, MA, USA), and GFP-CT-2A (a gift from A. Martinez, I.
Cajal, CSIC, Madrid, Spain) (Martinez-Murillo and Martinez,
2007), were grown in RPMI medium, 10% heat-inactivated
fetal bovine serum in 5% CO2 at 37 °C and 95% humidity.
Isolation and culture of cancer-initiating cells from
human glioblastoma samples
Glioblastoma (GBM) Tumor Stem Cells were isolated from 4
different human fresh GBM samples. Tissue samples were
obtained from patients operated at the Neurosurgery
department, Hospital la Fe, Spain. Permission for using this
material was obtained from the ethical review board in
Hospital la Fe, and written informed consent was obtained
from patients. GBM Tumor Stem Sells were cultured in media
containing: DMEM/F-12 (Gibco, 11039021) with Non-Essential
Amino Acids (10 mM; Gibco, 11140), Hepes (1 M; Gibco,
15630), D-Glucose 45% (Sigma, G8769), BSA-F5 7.5% (Gibco,
15260), Sodium Pyruvate (100 mM; Gibco, 11360), L-Gluta-
mine (200 mM; Gibco), Antibiotic–Antimycotic (100×; Gibco,
15240), N-2 Supplement (100×; Gibco, 17502), Hydrocortisone
(1 μg/μl; Sigma, H0135), Tri-iodothyronine (100 μg/ml;
Sigma, T5516), EGF (50 ng/μl; Sigma, E9644), bFGF (25 ng/μl;
Sigma, F0291) and Heparin (1 ng/μl).
Surgical procedures
Mice were anesthetized intraperitoneally with 100 mg/kg of
ketamine and 10 mg/kg of xylacine, their heads were
immobilized on a stereotaxic frame and intracranially
injected with 1 μl of Nilo1–mGNPs in the right striatum
at coordinates +0.9 mm anterior, +0.75 mm lateral, and
−2.75 mm ventral from bregma point. In control animals, PBS
buffer was injected. Brain fixations were performed on
anesthetized mice by transcardiac perfusion with 4% parafor-
maldehyde (PF) in 0.1 M phosphate buffer (fixation buffer).
Brains were extracted and post-fixed overnight at 4 °C inFigure 1 Nilo1 mAb identifies type B astrocytes in the adult br
subventricular zone from wild type mice by confocal microscopy sho
triple labeling Nilo1, GFAP and Nestin, indicating that the Nilo1+ cel
these panels are shown in Supplemental Fig. S1. B, Nilo1+ cells are C
short pulse of BrdU (50 mg/kg, 1 h before sacrifice) expressing high l
different from Nilo1+ cells (middle panels) and from neuroblasts (Ni
demonstrating that Nilo1+ cells are different form Nilo2+ cells (neuro
cortex) from E10 mouse embryos double stained with Nilo1 and eithe
lateral ventricle. V, ventricle. P, pial surface. Scale bars: 50 μm.
Supplemental Fig. S3). E, Human primary glioblastoma growing in vit
a secondary FITC mouse IgG anti-hamster Ig (green) (left) and count
right panels (controls and the staining of other 4 human glioblastomfixation buffer and cryoprotected in fixation buffer with 30%
sucrose for two days at 4 °C before freezing at −80 °C. Fixed
brains were cut with a cryostat (25 μm thick) and slices were
maintained at −20 °C in 30% (v/v) glycerol, 30% (v/v)
etilenglicol, PB 0.1 M pH 7.4 until analyzed.
Tumors were generated by grafting 102–2 × 105 CT-2A
(or GFP-CT-2A) cells intracranially at stereotaxic coordi-
nates +0.1 mm anterior, −2.25 mm lateral, and −2.70 mm
ventral into the right caudate putamen, in 1 μl of PBS (n = 6
for MRI analyses).
Demyelination was induced by injecting 1 μl of 2% LPC in PBS
near the corpus callosum, at stereotaxic positions +1 mm
anterior, −1 mm lateral, and −2 mm ventral from bregma
point, on anesthetized mice. Mice (n = 6) were sacrificed 7 or
25 days later.
Mechanical injuries were made on anesthetized mice by
inserting a Hamilton needle by stereotaxic surgery (coordi-
nates +0.9 mm anterior, +0.9 mm lateral, −2.75 mm ven-
tral refereed to bregma point) (n = 6). In some mice, the
lesion site was labeled by nigrosine (0.5 μl i.c. containing
0.5 ng/μl in sterile PBS). Mice were sacrificed one to three
days later.
The cryolesion was generated by applying for 10 s a dry
ice pellet onto the left frontoparietal bone of anesthetized
mice. Mice (n = 5) were sacrificed three days later.Magnetic resonance imaging
MRI studies were performed on a Bruker Biospec 70/20
scanner using a combination of a linear coil (for transmis-
sion) with a 4-element mouse head phased array coil (for
reception). Animals were anesthetized with sevofluorane
(5% for induction and 2% for maintenance) and placed in an
MRI-adapted stereotaxic holder. Respiration and body
temperature were continuously monitored. MRI acquisition
protocol included an initial flash sequence (repetition time:
100 ms, echo time: 6 ms, field of view: 4 cm, matrix:
128 × 128) to center the Field of View (FOV), followed by a
shimming procedure applied to a region of interest cover-
ing the head (FOV = 3 × 2 × 2 cm, matrix = 64 × 64 × 64)
based on a Field Map sequence (TR = 20 ms, TE = 1.43 and
5.42 ms).
As an anatomical reference, a T2-weighted axial study
(TR = 2500 ms; TE, 33 ms; α = 180°; FOV = 2 × 2 cm; ma-
trix = 256 × 256; slice thickness = 0.5 mm, 15 slices to cover
the whole brain) was used and nanoparticles were detected
and tracked with a T2*-weighted 3D multi gradient echoain, as well as embryonic radial glia. Immunohistochemistry of
wing A, double staining with Nilo1 and Sox2, Nestin, GFAP or a
ls are positive for these markers. Single and double stainings for
D24− and had a subependymal localization. Cells labeled with a
evels of Pax6 (see arrows), corresponding to the C population are
lo2+ cells, right panel). C, Double staining with Nilo1 and Nilo 2
blasts). D, Immunohistochemistry of fixed brains (telencephalic
r nestin or vimentin. Nuclei were counterstained with DAPI. LV,
Localization of this region on the mouse embryo is shown in
ro as neurospheres was stained with Nilo1 mAb and revealed with
erstained with DAPI (middle). The merged picture is seen on the
a cell lines are shown in Supplemental Fig. S4).
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118 G. Elvira et al.(MGE) sequence (TR = 200 ms; 8 echoes, TE = 10 to 45 ms;
echo spacing = 5 ms; α = 15°; FOV = 1.6 × 1.6 × 1.5 cm;
matrix = 192 × 96 × 96).
To increase the signal-to-noise ratio (SNR) and improve
image contrast, the different echo images from the MGE
sequence were added (in magnitude). To display the results,
the tumor area was manually segmented on the T2 axial
scans and transferred to the MGE image.Immunological analyses and staining procedures
Single cell suspensions from cultured neurospheres were
attached onto Matrigel Basement Membrane Matrix Growth
Factor Reduced (BD Pharmingen) pre-coated coverslips with
diluted in culture media (1:20 v/v) as described (Elvira et
al., 2012). Cells were fixed with 4% PF in PBS buffer for
15 min at RT. Quenching was performed by adding 0.1 M
glycine pH 7.4 for 15 min at RT. After three PBS washes,
blocking was performed by incubating the coverslips with
10% goat serum in PBS during 1 h at RT. Fixed cells were
incubated overnight with Nilo1–mGNPs or purified Nilo1
mAb at 4 °C. After three PBS washes, cells were incubated
with anti-Ha-FITC secondary antibody 1:100 for 1 h.
To assess whether MRI signals corresponded to labeled
type B astrocytes, brains from mice used in MRI analyses
were fixed and cryopreserved for cryostat sectioning in a
plane parallel to that of axial MR imaging. Serial 20–25 μm
thick frozen sections were collected through the entire
mouse brain. Anatomical landmarks such as corpus callosum,
lateral ventricles opening, shape and anterior commisure of
the brain were used for the spatial alignment of MRI and
immunohistochemical sections.
Brain sections of wild type mice or mice intracranially
injected with Nilo1–mGNPs were blocked with 10% mouse
serum in PBS during 1 h at RT and stained with the appropriate
antibodies (Supplemental Table S1). For the identification of
Nilo1+ cells on Nilo1–mGNP injected mice, anti-Ha-FITC
(1:100) or, alternatively, anti-hamster biotin (1:100) followed
by streptavidin-A488 (1:400) or streptavidin-Texas Red
(1:400) was used. Coverslips were mounted with an
anti-fade (Mowioll488), counterstained with either DAPI orFigure 2 Nilo1–mGNPs revealed MRI hypointense signals in b
nanoparticles were made of a magnetic Fe3O4 core, covered by a go
carboxyl-ending linker to which Protein G was coupled and Nilo1 m
intracranially injected with Nilo1–mGNPs. Brain sections were dir
antibody and revealed with streptavidin A488. DAPI was used to co
microscopy of Nilo1–mGNPs (top) and Nilo1 mAb (bottom) label
counter-stain nuclei. Scale bar: 25 μm. D, Flow cytometry analyses o
gray) or Nilo1 alone (dark gray) both revealed with a fluorescent sec
the absence of Nilo1 were used as negative control (black line). E
astrocytoma cells (left hemisphere, d0) and Nilo1–mGNPs contralate
Nilo1–mGNPs injection day is indicated with an arrowhead and MR
nanoparticle injection (filled). G, Axial view of T2 MRI image of mou
was drawn delimiting the tumor mass. H, Representative T2* MRI stu
3). Axial, coronal and sagittal views just before (−1 h) or 3 h, 24 h, 4
the injection site of Nilo1–mGNPs (a more rostral position than the
changes from H. The increase in the accumulation of nanoparticles
intensity in the region of interest. The controls are shown in SuppleHoechst 33342. Images were collected with a Leica
TCS-SP5-AOBS confocal microscope (Mannheim, Germany).
Detection ranges were set to eliminate crosstalk between
fluorophores.
For in vivo identification of Nilo1+ cells surrounding the
brain tumor, mice were intraperitoneally injected with
Nilo1 ascites at 10 μg/g of body weight one week after
stereotaxic injection of 100 GFP-CT-2A cells. Mice were
sacrificed 24 h later and 25 μm sections of fixed brains were
analyzed using a secondary Cy5.5-labeled anti-hamster
antibody.
Short BrdU labeling in vivo. Mice were intraperitoneally
injected with a single dose of BrdU (50 mg/kg). Mice were
sacrificed 1 h later and 25 μm cryostate sections were
collected. Fixed brain sections were denatured with 2 N
HCl in PBS, 0.3% Triton X-100 (PBST) during 30 min at
37 °C. After PBST washes, sections were blocked with 10%
goat serum in PBST and incubated with a secondary
FITC-labeled anti-BrdU antibody during 24 h at 4 °C. The
Pax6high BrdU+ population labeled with this protocol
represents the type C transit amplifying progenitors (Aguirre
and Gallo, 2004; Kim et al., 2009; Parras et al., 2004). These
samples were additionally stained with either Nilo1 or Nilo2
mAbs.
C57Bl/6 mouse embryos were obtained in E10 develop-
ment stage, fixed by immersion in fixation buffer overnight
at 4 °C and cryoprotected in fixation buffer with 30%
sucrose for two days at 4 °C before freezing in OCT blocks.
Cryostat sections of the embryos were mounted in
poly-lysine slides and maintained at −20 °C until analyzed
(histology service in CNB-CSIC, Madrid, Spain). Radial glia
was identified by using vimentin and nestin antibodies in a Leica
TCS-SP5-AOBS confocal microscope (Mannheim, Germany).
Images of E10 mouse embryo used to compose overview used
in Supplemental Fig. S1 were collected in a Leica AF6000 LX
Live Cell Imaging microscope (Mannheim, Germany).Flow cytometry
Single cell suspensions from neurospheres were obtained
after incubation with accutase (5 min, 37 °C). Unspecificrain tumor sites. A, Cartoon representing Nilo1–mGNPs. The
ld shell (Au) and subsequently coated with carbohydrates and a
Ab bound. B, In vivo identification of SVZ Nilo1+ cells in mice
ectly incubated with a secondary biotinylated anti-hamster Ig
unter-stain nuclei. Scale bar: 25 μm. C, Fluorescence confocal
ed neurosphere cells grown in MatrigelTM. DAPI was used to
f SVZ-derived neurosphere cells stained with Nilo1–mGNPs (light
ondary antibody. Cells incubated with the secondary antibody in
, Schematic representation of the injection sites for the CT-2A
rally in a more rostral position. F, Experimental schedule where
I acquisitions are shown with asterisks, before (empty) or after
se injected with CT-2A cells (d0) and Nilo1–mGNPs. Dotted line
dy of mice injected with CT-2A cells (d0) and Nilo1–mGNPs (n =
8 h after nanoparticle injection. Inset in axial panel at 3 h shows
CT-2A injection site). I, Quantification of MRI signal intensity
surrounding the tumor is translated as a drop in the mean signal
mentary Fig. S5.
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BSA, 0.0025% NaN3 for 30 min at 4 °C. An excess of Nilo1–
mGNPs was added to the cell suspension and incubated for1 h at 4 °C. Cells with purified Nilo1 were incubated as a
positive control. After PBS washes, cell suspensions were
stained with anti-Ha-FITC (1:100 diluted in PBS, 5% BSA,
120 G. Elvira et al.0.025% NaN3). Following additional PBS washes, cells were
resuspended in 300 μl cold PBS until FACS measurements
(Epics XL, Coulter). Propidium iodine was added (25 μg/ml)
to each sample to gate on living cells.
T2* MRI signal quantification
The accumulation of nanoparticles over time is reflected as an
increase in the T2* hypointensity, equivalent to a drop in the
overall intensity of the MRI signal. To evaluate the accumu-
lation of nanoparticles, we measured signal intensity levels in
the T2*-weighted images over time. For each animal, a region
of interest (ROI) including the tumor area and its surroundings
was manually delimited on the anatomical images (T2-weight-
ed), at the final time point of the experiment. This ROI was
translated to the T2*-weighed images (all images were
previously co-registered) and the overall intensity value in
the volume of interest was computed for each day of
experiment on all the MRI sections. This processing was
performed with the software MMWKS (Multimodality WorkSta-
tion) (Pascau et al., 2006). Signal intensity levels over time are
expressed as percentage of the baseline T2* intensity for each
animal and represented as mean ± S.D.
Results
Nilo1 mAb identifies type B astrocytes in the SVZ
niche
Nilo antibodies were developed and characterized in our
laboratory. Whereas Nilo2 mAb recognizes surface antigens
expressed in neuroblasts, Nilo1 was described as identifying
Sox2+, GFAP+, vimentin+, EGFR+, DCX−, PSA-NCAM−, and
Tuj1− cells (Del Valle et al., 2010), suggesting that it
identifies a highly undifferentiated neural precursor. Here
we corroborated that Nilo1 recognized Nestin+, GFAP+ and
Sox2+ at the SVZ niche (Fig. 1A, Supplemental Fig. S1). The
antigen recognized by Nilo1 mAb was not expressed in
ependymal cells at the wall of the lateral ventricles (CD24+)
(Fig. 1B). In addition, Nilo1+ cells did not correspond to type
C cells (identified by a short pulse of BrdU and co-expressing
high levels of Pax6 (Aguirre and Gallo, 2004; Kim et al.,
2009; Parras et al., 2004)), since the BrdU+Pax6high and the
Nilo1+ cells represented two distinct populations (Fig. 1B).
As control, we show that a short pulse of BrdU did not label
neuroblasts (Fig. 1B). Furthermore, Nilo1 identified differ-
ent cell populations than Nilo 2 (Fig. 1C), excluding the
possibility that Nilo1 recognized neuroblasts (Nilo2+) (Del
Valle et al., 2010). Moreover, the antigenic phenotype of
Nilo1+ cells allowed us to exclude that they could represent
either intermediate progenitors such as NG2-glia, which are
GFAP− (Dawson et al., 2003; Nishiyama et al., 2005), or
differentiated astrocytes, since there is no Nilo1 signal in the
brain cortex (Supplemental Fig. S2). Taken together, these
data indicated that Nilo1 mAb identified surface antigens in
SVZ-derived type B astrocytes, defined in adult mice as
neural stem cells, since Nilo1+ cells i) had a subependymal
localization and did not recognize ependymal CD24+ cells,
ii) did not represent type C cells, iii) identified a population
distinct from neuroblasts, iv) did not represent differenti-
ated astrocytes nor intermediate progenitors NG2-glia like,
and v) identified SOX2+, nestin+GFAP+ cells. Further supportto this notion came from the observation that on E10 mouse
embryos, the radial glia markers vimentin and nestin (Mori
et al., 2005) identified the same cells as Nilo1 (Fig. 1D and
Supplemental Fig. S3).
In addition, we have been able to show that Nilo1 mAb
recognized surface antigens in primary human glioblastoma
cell lines growing as neurospheres (Fig. 1E and Supplemen-
tal Fig. S4). Indeed, we have analyzed 5 primary human
glioblastoma cell lines, derived from 4 different patients and
in all of them there were cells positively stained with Nilo1
mAb. These data indicate that this mAb is able to recognize,
in addition to the mouse antigens against which they were
raised, the homologous antigen in humans.In vivo tracking of Nilo1+ cells mobilized towards an
induced glioblastoma
We have previously described, using protein G functional-
ized magnetic glyconanoparticles (mGNPs) bound to the
monoclonal antibody Nilo2, that Nilo2+ neuroblasts migrate
towards an induced glioblastoma, and that this migration is
ordered and fast (Elvira et al., 2012). In order to assess whether
more undifferentiated precursors (type B cells) were also able
to migrate to an induced tumor, we coupled Nilo1 mAb to the
same mGNPs (Fig. 2A), which had been fully characterized
elsewhere in terms of size core, shell composition, relaxivity
and functionality (Elvira et al., 2012; Gallo et al., 2010; Gallo
et al., 2011). Functionality of the Nilo1–mGNPs was evaluated
by flow cytometry, immunocytochemistry and immunohisto-
chemistry of the SVZ following in vivo injection of the Nilo1–
mGNP particles (Figs. 2B–D). A stereotaxic graft of CT-2A
astrocytoma cells (102–104 cells) into the left hemisphere
(Fig. 2E) generated a highly reproducible glioblastoma at the
injection site, which was followed by T2 magnetic resonance
imaging (MRI) over time (Fig. 2F), demonstrating that it was
grown on day 11 (Fig. 2G). At this time, Nilo1–mGNP complexes
were intracranially injected by stereotaxic surgery into the
right hemisphere (Figs. 2E, F) of anesthetized mice, which
were subsequently imaged by MRI using T2* sequences
(Fig. 2H). T2*-weighted MRI studies obtained 1 h before
Nilo1–mGNP injection (d11, −1 h) were used as baseline for
the experiment. To establish basal hypointensities on the MRI
experiments several controls were made, including mice
injected with PBS, to evaluate effects due to intracranial
surgery (Supplemental Fig. S5 A,B); mice injected with CT-2A
cells either alone (Supplemental Fig. S5 C,D) or in combination
with an isotopic control antibody (CD3ε, developed in hamster)
coupled to mGNPs, to evaluate signals due to either tumor
growth or unspecific movement of mGNPs (Supplemental Fig.
S5 E,F). None of this controls showed defined hypointense
signals on T2*-weighted MRI studies.
The first T2*MRI study after Nilo1–mGNPs injection (d11,
3 h) allowed us to discard that the complexes were directly
deposited in the cerebrospinal fluid (inset on Fig. 2H). At
this time, in addition to black spots in the lateral ventricles,
which corresponded to Nilo1+ cells in their niches, we
detected an increase in the signal hypointensities around
the tumor, as compared with the baseline images (Fig. 2H
d11, 3 h). These changes could not be explained by
neo-vascularization during the four-hour lapse between
MRIs. The hypointense T2* signals surrounding the tumor
Figure 3 Migration of B astrocytes towards the tumor site occurs within hours following the insult. A, Experimental schedule where
Nilo1–mGNPs injection day is indicated with an arrowhead and MRI acquisitions are shown with asterisks, before (empty) or after
tumor cell injection at d0 (filled). B, Representative axial view from the experiment (n = 3) showing T2* MRI of a mouse injected with
Nilo1–mGNPs (d4) and CT-2A cells (d0), analyzed just before (−1 h) or 3.5 h, 2 or 7 days after tumor injection (left column). T2 MRI
analysis was used to follow tumor growth (right column). Arrowhead indicates hypointense signals accumulated just after tumor cell
injection. C, Quantification of MRI signal intensity changes from B. The increase in the accumulation of nanoparticles surrounding the
tumor is translated as a drop in the mean signal intensity in the region of interest. The controls are shown in Supplementary Fig. S4.
D–I, Immunohistochemical analyses of fixed brains from mice analyzed by MRI either 24 h (D–G), or seven days (H, I) after the lesion.
Nilo1+ cells were detected by incubation with a secondary biotinylated anti-hamster Ig antibody and revealed with streptavidin A488.
Double labeling with DCX (E), EGFR (G) or Sox2 (I). The MRI hypointense signals detected 3.5 h after tumor cell injection which are
maintained and accumulated with time (up to 7 days) corresponded to Nilo1+ cells which had arrived at the lesion site as
undifferentiated B astrocytes. LV, lateral ventricle. Scale bars: 50 μm.
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Figure 4 The MRI hypointense signals surrounding the tumor correspond to B astrocytes. Immunohistochemical analyses of fixed
brains from mice analyzed in Fig. 2 two days after the Nilo1–mGNP injection (d13). Since Nilo1 mAb was already present in the Nilo1–
mGNPs, Nilo1+ cells were revealed by incubation with a secondary biotinylated anti-hamster Ig antibody and streptavidin-A488. A, B,
SVZ ipsilateral to the Nilo1–mGNPs injection site demonstrating the presence of type B astrocytes (Nilo1+ GFAP+ or Nilo1+Sox2+)
exiting the anterior horn (AH) of the lateral ventricle. C–H, Type B astrocytes were also present at the tumor site vicinity since they
were Nilo1+GFAP+ (C–E) or Nilo1+EGFR+. F–H, Sites with MRI hypointense signals, indicating that Nilo1+ cells migrated to the tumor
site as B astrocytes. CC, corpus callosum; T, tumor. Scale bars: A–D, 50 μm; E–H and inset in B, 25 μm.
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the lesion site accumulated over time (Fig. 2H, d12, d13), as
quantified in Fig. 2I.To discard that at longer experimental times, part of the
hypointense signals could be due to neo-vascularization
associated with tumor growth, we analyzed the Nilo1+ cell
123Detection of mouse endogenous type B astrocytes migrating towards brain lesionsmigration when the tumor mass was not yet formed
(Fig. 3A). For this purpose, CT-2A cells were intracranially
injected (d0) four days after Nilo1–mGNP injection (d4).
Baseline T2*-weighted MRI images were taken 1 h prior to
CT-2A injection, failing to detect any hypointense signal at
the astrocytoma injection site (Fig. 3B, d0, −1 h). Howev-
er, as soon as 3.5 h after injection of the CT-2A cells, an
accumulation of hypointense spots at the cell injection site
was detected (Fig. 3B, arrowhead d0, 3.5 h) in all analyzed
mice. T2-weighted MRI studies (Fig. 3B) enabled the detection
of the lesion produced by the stereotaxic injection of the
needle to graft the tumor cells (d0, 3.5 h; d2) and the
subsequent tumor formation (d7). An increase with time of
hypointense signals (T2*-weighted MRI) was detected at this
position (Figs. 2B, C) including the needle track (where CT-2A
cells could have also been deposited) (d2), accumulating
around the tumor when it was formed (d7). During these
analyses, tumor-induced angiogenesis was undetectable,
since in this glioblastoma model increases on days 12 to 14
(Fig. 2H, Supplemental Fig. S5 D, F).
To demonstrate that the hypointense signals detected by
T2* MRI corresponded to Nilo1+ cells, fixed tissues of the mice
used in these MRI experiments were analyzed by immunohisto-
chemistry. Since these tissue sections already contained
Nilo1–mGNPs, the presence of Nilo1+ cells was directly revealed
with a fluorescently labeled specific secondary antibody.
In the experiments where Nilo1–mGNPs were injected
before the CT-2A tumor cells, as soon as 24 h after the damage
in the left striatum, we observed a SVZ thickening, concomitant
with the presence of neuroblasts (DCX+) and a high number of
Nilo1+ cells dispersed outside their usual subependymal
location, infiltrating the adjacent striatum (Figs. 3D, E). This
unusual location for Nilo1+ cells, it could represent cells
migrating from the lateral ventricle walls towards the
adjacent parenchyma. In addition, in vivo labeled Nilo1+
cells surrounding the lesion site were detected, confirming
the MRI data (Fig. 3F). Moreover, Nilo1+ cells were also
EGFR+, supporting the notion that these cells arrived
undifferentiated at the lesion site (Fig. 3G). Even seven
days after the damage, we still detected Nilo1+ Sox2+ cells
between the niche and the damage site and surrounding the
tumor (Figs. 3H, I).
These data were confirmed by immunohistochemistry
analyses on the converse experiment where the CT-2A tumor
was formed before the injection of the Nilo1–mGNPs, Nilo1+
cells crossing the corpus callosum from the SVZ towards the
lesion site were revealed 3 days after Nilo1–mGNP injection
(13 days after tumor injection) (Figs. 4A, B). Conversely, on
animals devoid of lesion, Nilo1+ cells were circumscribed to
the anterior horn and walls of the lateral ventricles (Fig. 1C)
(Del Valle et al., 2010), showing the migration specificity of
the labeled cells. In addition, Nilo1+ cells expressed
additional stem cell markers while migrating (GFAP+SOX2+)
or even at the final destination surrounding the tumor
(GFAP+SOX2+EGFR+) (Fig. 4) suggesting that these cells
migrated undifferentiated.
Migration of Nilo1+ cells is a general trait for brain
injury
To ascertain whether the migration of B astrocytes was
restricted to the presence of tumor cells or rather to a moregeneralized response mechanism to brain damage, we
analyzed for the presence of type B astrocytes in the
neighborhood of three different kinds of brain injuries.
Firstly we used a cryolesion model, which consists of
applying dry ice over the left frontal bone for a short time.
This model of brain injury generates an initial tissue damage
which leads to secondary processes such as cell death,
inflammation, vascular edema and blood–brain barrier
disruption (Raslan et al., 2012). In this model Nilo1+ cells
were detected on the vicinity of the lesion three days after
the injury by immunohistochemistry (Fig. 5A).
In a second lesion model, we induced a focal demyelinated
lesion by lysolecithin (lysophosphatidilcholine, LPC) injection
into the left corpus callosum. The initial LPC effect is a
localized demyelination during the first week (Nait-Oumesmar
et al., 1999) and maintenance of inflammatory signals during
the second week (Cantarella et al., 2008). In these mice,
seven days after LPC injection, the optimal time for the
localized demyelinization, Nilo1+ cell recruitment around
the lesion site was detected (Fig. 5B) in sites containing
GFAP+ or Sox2+ cells (data not shown). Furthermore,
twenty-five days after LPC injection, when remyelination
could be confirmed by the presence of O4+ or myelin+ cells,
we also detected neuroblasts (Nilo2+) adjacent to remyelinated
cells (Fig. 5C).
The third injury model consisted of a cortical mechan-
ical lesion induced by the puncture with a stereotaxic
needle, where the damage site was revealed by injection of
nigrosine. We could detect Nilo1+ cells migrating to the
damage site one to three days after the mechanical injury
(Fig. 5D) in a location similar to that where neuroblasts were
identified (Fig. 5E).
Migration of Nilo1+ cells is associated with adult
radial glia
Few hours after injuries produced by needle injection, the
wound surrounding the needle track was filled by structures
expressing Nilo1 (Fig. 6A). These processes might represent
adult radial glia, since they express not only Nilo1 but also
the glial marker GFAP, are associated to PSA-NCAM and to
the erythrocyte markers Ter119+, CD24+, whereas did not
represent reactive astrocytes since they were negative for
vimentin and CD11b (Fig. 6B and data not shown).
Intraperitoneally injected Nilo1 mAb enables in vivo
identification of brain glioblastomas
Since high grade brain tumors induce the blood–brain barrier
breakdown (Wolburg et al., 2012), oneweek after intracranially
injecting CT-2A-GFP cells, we administered intraperitoneally a
single dose of Nilo1mAb (10 μg/g of bodyweight) and sacrificed
themice the next day. In the fixed brains, the presence of Nilo1
was revealed by immunohistochemistry with a fluorescently
labeled secondary antibody, demonstrating the presence of
type B cells surrounding the GFP+ glioblastoma cells (Fig. 7A).
The use of GFP tumor cells allowed us the identification of host
cells (Nilo1+ GFP−, arrowheads in Fig. 7B) in areas where
isolated tumor cells infiltrated the parenchyma. This experi-
ment corroborated the notion that type B astrocytes migrate
towards the tumor site and opens up the possibility of using
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Figure 6 GFAP+ Nilo1+ processes coalesced and filled the damaged tissue. A, Immunohistochemical analyses of fixed brains from
the needle track site on mice intracranially injected with CT-2A cells (top row) (n = 3) or PBS (bottom row) (n = 3) and analyzed by
confocal microscopy 24 h after the lesion. Staining with Nilo1-Cy5 allows detection, in addition to Nilo1+ cells from SVZ towards the
lesion site, of processes that at these early times fill the broken tissue (arrowheads). B, Double immunohistochemistry staining of
fixed brains from mice injected with PBS 24 h before, demonstrating that these Nilo1+ processes were compatible with adult radial
glia since they were Nilo1+GFAP+, where associated with PSA-NCAM+ structures and red blood cells Ter-119+, CD24+. These processes
did not represent reactive astrocytes since they were vimentin−. LV, lateral ventricle. Scale bars: A, left panels 50 μm, right panels
25 μm; B, 25 μm.
125Detection of mouse endogenous type B astrocytes migrating towards brain lesionsintraperitoneally injected antibodies to follow brain damage in
situations where the blood–brain barrier is disrupted.
Discussion
Although there are evidences that immature neurons
present in brain lesion sites, such as peri-infarcted tissue,
come from GFAP+ SVZ-derived neural stem cells (Garcia etFigure 5 Migration of B astrocytes occurred following several typ
confocal microscopy. A, Three days after a cryolesion, Nilo1+ cells w
magnification showing fluorescent (middle) or bright field (right p
vessels (n = 5). B, Seven days following a demyelination, Nilo1+ ce
panel) where they accumulated (right panel) (n = 3). C, This movem
myelin+ cells 25 days after demyelination (n = 3). D, Three days afte
(n = 6), Nilo1+ cells were detected surrounding the lesion site (le
microscopy. E, Three days after a mechanical damage produced by
filling the lesion site. Scale bars: A and B left panels, 150 μm; A, ceal., 2004; Ohab and Carmichael, 2008; Ohab et al., 2006), a
direct mobilization of type B astrocytes towards a lesion site
has not yet been reported.
To study the migration of early neural progenitors
towards a brain injury, we used Nilo1 mAb. Here we
demonstrate that Nilo1 identified type B astrocytes (or
adult neural stem cells) since i) it recognized GFAP+, Sox2+
and EGFR+ cells, being negative for the neuroblast markerses of injury. Immunohistochemistry of fixed brains analyzed by
ere present surrounding the lesion site (dotted line, left panel);
anel) microscopy where Nilo1+ cells were associated to blood
lls were found between the niche (LV) and the lesion site (left
ent of Nilo1+ cells was followed by the appearance of O4+ and
r a mechanical damage produced by stereotaxic injection of PBS
ft panel) revealed by nigrosine (right panel) on a bright field
stereotaxic injection of PBS, Nilo2+ neuroblasts were detected
ntral and right panels; B right panel, C–E, 50 μm.
Figure 7 In vivo identification of B astrocytes surrounding a brain tumor after intraperitoneal injection of the Nilo1 mAb.
Immunohistochemical analyses of fixed brain from mice injected with GFP-CT-2A cells (GFP+ in green) in the left striatum, in which
Nilo1 was intraperitoneally injected one week after tumor cell injection, and mice (n = 4) sacrificed 24 h later. A, Low and B, high
magnification showing that Nilo1+ cells surrounding the tumor were host-derived (left panel). An accumulation of Nilo1+ cells was
detected surrounding infiltrated tumor cells (right panel). Nilo1+ cells (red) were revealed with anti-hamster Cy5.5. Scale bars: A,
100 μm; B, 75 μm.
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having instead subependymal localization on the SVZ; iii)
transient amplifying cells (or type C cells, which are
Pax6highBrdU+ on tissue sections from in vivo labeled animals
with a short BrdU pulse) (Aguirre and Gallo, 2004; Kim et al.,
2009; Parras et al., 2004) and Nilo1+ cells represented two
distinct populations; iv) Nilo1+ cells were GFAP+, excluding
the possibility that this mAb identified intermediate pro-
genitors in the differentiation process, like NG2-precursors
which are GFAP− (Dawson et al., 2003; Nishiyama et al.,
2005); v) double staining of E10 embryo brains with Nilo1 and
either vimentin or nestin suggested that Nilo1 recognizes
embryonic radial glia.
Nilo1 mAb, coupled to functionalized magnetic nanopar-
ticles in combination with magnetic resonance imagingallowed us to identify the Nilo1+ cells at their niche in the
SVZ and, in animals carrying a lesion, at intermediate
positions between the niche and the lesion site, where
they accumulated over time. The migratory response was
very fast since MRI hypointense signals at the lesion site
were detected by MRI 3 h after injection of the Nilo1–mGNP
complexes in animals bearing tumors, or 3.5 h after injec-
tion of the CT-2A cells on animals that had previously been
injected with Nilo1–mGNP complexes. The presence of
Nilo1+ cells at the lesion site was corroborated by immuno-
histochemistry analyses on fixed brain sections from these
mice, incubating with a fluorescent secondary antibody,
since the Nilo1+ cells were already labeled in vivo with the
Nilo1–mGNPs. Immunohistochemistry confirmed not only
that the hypointense signals corresponded to Nilo1+ cells
127Detection of mouse endogenous type B astrocytes migrating towards brain lesionssurrounding the tumor, but also that these cells retained
their type B astrocyte phenotype (GFAP+, EGFR+, Sox2+)
following their migration.
The migration of adult neural stem cells (type B astrocytes)
towards a tumor site, rather than a tumor-specific response,
turned out to be a more generalized response to brain
insults since we detected Nilo1+ cells at the sites where
other types of lesions were produced (i.e. cryolesion,
demyelination, mechanical injury). These lesions were
chosen because they are very different from each other
and from the tumor implantation model described above. In
all of them, Nilo1+ cells were detected surrounding the
lesions, although we cannot formally exclude at this time
that some of the Nilo1+ cells surrounding the lesion
represent cells around the injury site de novo expressing
Nilo1 upon injury.
In addition to Nilo1+ cells migrating to the lesion sites,
both in a mechanical lesion model and after any stereotactic
injection, we detected, one day after the lesion, coalescing
structures filling the wound-lesion that expressed high levels
of Nilo1 antigen. These Nilo1+ processes were GFAP+,
vimentin− and CD11b−, forming structures associated to
PSA-NCAM. On the one hand, the observation that these
structures did not express vimentin or CD11b allowed us to
exclude that they represented proximal reactive astrocytes
(Holmin et al., 1997; Raedt et al., 2009; Ridet et al., 1997;
Robel et al., 2011). On the other hand, their GFAP+ staining
was compatible with the presence of adult radial glia fibers
or glial tubes. In physiological conditions they have been
described to support the migration of neuroblasts either
towards the olfactory bulb (Doetsch and Alvarez-Buylla,
1996; Ohab and Carmichael, 2008; Yang et al., 2005), acting
as substrate for the migrating progenitor cells after focal
apoptosis in the adult brain (Leavitt et al., 1999), or from
their proliferation zones to the lesion sites in adult brain in
fish (Clint and Zupanc, 2001; Zupanc and Clint, 2003). The
appearance of fibers either from astrocytes or adult radial
glia emanating from their SVZ subependymal position has
also been described not only under physiological conditions
(Kriegstein and Alvarez-Buylla, 2009; Thored et al., 2006;
Teramoto et al., 2003), but also in rodent or fish brain
lesions (Thored et al., 2006; Holmin et al., 1997; Ohab and
Carmichael, 2008; Clint and Zupanc, 2001; Zupanc and Clint,
2003; Szele and Chesselet, 1996). Radial glia cells have been
defined as neuronal precursors (Robel et al., 2011; Noctor et
al., 2001; Malatesta et al., 2000) and it has been suggested
that they could represent a specific subpopulation of
astrocytes in adult mammals (Kriegstein and
Alvarez-Buylla, 2009; Robel et al., 2011; Noctor et al.,
2001; Malatesta et al., 2000; Gubert et al., 2009).
Furthermore, the presence of radial glia in adult hippocam-
pus where neurogenesis occurs throughout life, or in
non-mammalian vertebrates where neurogenesis persists in
a rather wide-spread fashion in the adult brain (Clint and
Zupanc, 2001; Pinto and Gotz, 2007), raise the possibility
that the neurogenic potential of radial glia may extend into
adulthood in some brain regions (Noctor et al., 2001) or even
as an acute response to brain lesions, were neurogenesis is
necessary and commonly associated to brain tissue repairing
processes.
Interestingly, the migration kinetics of type B astrocytes
was similar to that previously described for neuroblasts(Elvira et al., 2012). This suggests that both cell types are
able to respond to the same “damage signals” and that type
B astrocytes could help in neuroblast migration as previously
suggested from in vitro (Song et al., 2002; Lim and Alvarez-
Buylla, 1999) or in vivo data (Kriegstein and Alvarez-Buylla,
2009; Leavitt et al., 1999; Noctor et al., 2001; Alvarez-Buylla
and Nottebohm, 1988). Nilo1+ radial glia-like processes report-
ed here support the notion that radial glia is a mainstay for
neurogenesis not only during the embryonic stage but also
during adulthood.
The migration of neural stem cells reported here is fully
in accordance with data showing that stimulation with
exogenous growth factors increase cell proliferation at the
SVZ and promote the migration of SVZ-derived cells into the
adjacent parenchyma or even at the vicinity of a brain
lesion site (Cantarella et al., 2008; Teramoto et al., 2003;
Craig et al., 1996; Doetsch et al., 2002; Gonzalez-Perez
et al., 2009). Growth factor infusions also increased the
number of GFAP+ cells exhibiting long processes that link the
ischemic striatum to the SVZ niche (Teramoto et al., 2003).
The lesion it self induces the secretion of growth and trophic
factors (Sundholm-Peters et al., 2005; Goings et al., 2004;
Ridet et al., 1997; Suzuki et al., 2012) that could activate
quiescent precursors (Ridet et al., 1997) or modify astrocyte
morphology (Junier, 2000) resulting in the mobilization
SVZ-derived cells.
Finally, by definition of the experimental procedures
presented here, the positions where the grafted tumors
will grow are already known, and therefore cannot be used
from the diagnostic point of view, the data presented here
represent a proof of concept that MRI using Nilo1–mGNPs
could be used in humans for detection of brain primary
tumors or recidives very early on, before contrast sub-
stances such as gadolinium would give a detectable signal,
in particular since we have been able to show that Nilo1
mAb is able to identify the corresponding antigens present
in human glioblastoma derived cells.
Conclusions
In summary, our data show that by combining Nilo1, a
monoclonal antibody able to identify surface antigens in
type B astrocytes and radial glia during development, with
superparamagnetic nanoparticles, the adult neural stem
cells can be identified in their niches and follow their fast
and orderly migration towards a lesion site in vivo using MRI.
Furthermore, the migration of these cells towards a lesion
site seems to be a general trait, since it can be detected
during development of a tumor, following a cryolesion,
demyelination or even a mechanical injury, generating in
addition few hours after the damage radial glia-like structures
at the lesion site.
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.scr.2014.11.006.
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